世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000042089

ポータブル超音波市場‐2030年までの世界予測

MarketsandMarkets

Portable Ultrasound Market - Global Forecast to 2030

発刊日 2025/07

言語英語

体裁PDF

ライセンス/価格

0000042089

Single
5-user
Corporate
Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ポータブル超音波市場:製品別 (プローブ、システム&コンソール、ソフトウェア、サービス)、プラットフォーム別 (トロリー/カート、ハンドヘルド、ラップトップ/タブレット)、用途別 (外傷、産婦人科、心臓病、血管、小児科)、エンドユーザー別 (病院、画像センター) - 2030年までの世界予測

世界の超音波市場は、2025 年の 24 億 9,000 万ドルから 2030 年までに 38 億 4,000 万ドルに成長し、この期間中の CAGR は 9.0% になると予想されます。2024年現在、ポータブル超音波市場の有力企業は、フィリップスヘルスケア (オランダ)、GEヘルスケア (米国)、キヤノンメディカルシステムズ株式会社 (日本)、シーメンス・ヘルティニアーズ (ドイツ)、富士フイルムホールディングス株式会社 (日本)など。

レポート詳細

目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 PORTABLE ULTRASOUND MARKET SEGMENTATION AND REGIONAL SNAPSHOT
1.3.2 INCLUSIONS AND EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Customer-based market estimation
2.3 MARKET FORECASTING APPROACH
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 MARKET SHARE ASSESSMENT
2.6 RESEARCH ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN THE PORTABLE ULTRASOUND MARKET
4.2 NORTH AMERICA: PORTABLE ULTRASOUND MARKET, BY COUNTRY AND END USER, 2024
4.3 GEOGRAPHIC SNAPSHOT OF PORTABLE ULTRASOUND MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Growing demand for point-of-care diagnostics
5.2.1.3 Rising technological advancements in portable ultrasound devices
5.2.1.4 Growing public and private investments, funding, and grants
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursements
5.2.3 OPPORTUNITIES
5.2.3.1 Integration of AI in portable ultrasound
5.2.3.2 High growth potential in emerging economies
5.2.3.3 Development of wearable and wireless ultrasound devices
5.2.4 CHALLENGES
5.2.4.1 Limited battery life and device durability
5.2.4.2 Shortage of skilled sonographers
5.3 VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 PROMINENT COMPANIES
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.4.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
5.4.4 END USERS
5.5 PORTER'S FIVE FORCES ANALYSIS
5.5.1 THREAT OF NEW ENTRANTS
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.6.2 BUYING CRITERIA
5.7 PATENT ANALYSIS
5.8 TRADE DATA ANALYSIS
5.8.1 IMPORT DATA
5.8.2 EXPORT DATA
5.9 KEY CONFERENCES AND EVENTS, 2025-2026
5.10 UNMET NEEDS AND KEY PAIN POINTS
5.11 ECOSYSTEM ANALYSIS
5.12 IMPACT OF 2025 US TARIFFS
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRY/REGION
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.4.4 Impact on end-user facilities
5.13 IMPACT OF GEN AI ON PORTABLE ULTRASOUND MARKET
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 Probes
5.15.1.2 Contrast-enhanced portable ultrasound
5.15.1.3 Portable and handheld ultrasound devices
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Elastography
5.15.2.2 Transrectal Ultrasound
5.15.2.3 Transvaginal Ultrasound
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 Positron emission tomography and computed tomography
5.16 CASE STUDY ANALYSIS
5.16.1 EFFICIENT POWER FOR HANDHELD ULTRASOUND UNITS
5.16.2 ADVANCEMENTS IN USING PORTABLE ULTRASOUND WITH ARTIFICIAL INTELLIGENCE IN PRE-HOSPITAL EMERGENCIES AND DISASTER RESPONSE SETTINGS
5.16.3 EFFECTIVENESS OF HANDHELD PORTABLE ULTRASOUND IN RURAL HOSPITAL IN GUATEMALA
5.17 REGULATORY LANDSCAPE
5.17.1 NORTH AMERICA
5.17.1.1 US
5.17.1.2 Canada
5.17.2 EUROPE
5.17.3 ASIA PACIFIC
5.17.3.1 Japan
5.17.3.2 China
5.17.3.3 India
5.17.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.18 INVESTMENT AND FUNDING SCENARIO
5.19 PRICING ANALYSIS
5.19.1 AVERAGE SELLING PRICE TREND, BY REGION
5.19.2 AVERAGE SELLING PRICE OF HANDHELD ULTRASOUND BY KEY PLAYERS (USD), 2024
5.20 REIMBURSEMENT SCENARIO

6 PORTABLE ULTRASOUND MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION
6.2 TRANSDUCERS/PROBES
6.2.1 CURVILINEAR/CONVEX ARRAY
6.2.1.1 Allows for wide-field imaging and better visualization of structures at depth
6.2.2 LINEAR ARRAY
6.2.2.1 Versatile tool in ultrasound imaging
6.2.3 PHASED ARRAY
6.2.3.1 Ability to steer and focus the portable ultrasound beam electronically to drive growth
6.2.4 OTHER ARRAY TYPES
6.3 SYSTEMS & CONSOLES
6.3.1 ADVANCED IMAGING CAPABILITIES AND ROBUST PERFORMANCE TO DRIVE GROWTH
6.4 ACCESSORIES
6.4.1 CRITICAL TO ENSURING IMAGE QUALITY, USER CONVENIENCE, AND INFECTION CONTROL ACROSS CLINICAL ENVIRONMENTS
6.5 SOFTWARE & SERVICES
6.5.1 ADVANCED FEATURES LIKE REAL-TIME IMAGE GUIDANCE, CLOUD-BASED IMAGE STORAGE AND SHARING, AND AUTOMATED DIAGNOSTICS TO DRIVE GROWTH

7 PORTABLE ULTRASOUND MARKET, BY PLATFORM
7.1 INTRODUCTION
7.2 TROLLEY/CART BASED
7.2.1 INCREASED USE IN ACUTE CARE SETTINGS AND EMERGENCY CARE IN HOSPITALS TO DRIVE GROWTH
7.3 HANDHELD
7.3.1 INCREASING NUMBER OF TRAUMA/EMERGENCY CASES TO DRIVE DEMAND
7.4 LAPTOP BASED
7.4.1 ABILITY TO DELIVER NEAR-CART-LEVEL PERFORMANCE IN A COMPACT FORM TO DRIVE GROWTH
7.5 TABLET BASED
7.5.1 LIGHTWEIGHT AND USER-FRIENDLY DESIGN TO DRIVE DEMAND

8 PORTABLE ULTRASOUND MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & SURGICAL CENTERS
8.2.1 INCREASING NUMBER OF CANCER CASES TO DRIVE DEMAND
8.3 IMAGING CENTERS
8.3.1 NEED FOR STREAMLINED WORKFLOWS AND POINT-OF-CARE DIAGNOSTICS TO DRIVE GROWTH
8.4 AMBULATORY CARE CENTERS
8.4.1 INCREASING DEMAND FOR COMPACT PORTABLE ULTRASOUND DEVICES TO DRIVE GROWTH
8.5 OTHER END USERS

9 PORTABLE ULTRASOUND MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 OBSTETRICS/GYNECOLOGY
9.2.1 ADOPTION OF AI IN PORTABLE ULTRASOUND TO DRIVE SEGMENTAL GROWTH
9.3 OTHER APPLICATIONS
9.4 CARDIOLOGY
9.4.1 RISING PREVALENCE OF CARDIAC DISEASES TO DRIVE DEMAND
9.4.2 ORTHOPEDIC AND MUSCULOSKELETAL
9.4.2.1 Rising prevalence of osteoarthritis to drive growth
9.5 VASCULAR
9.5.1 NEED FOR EARLY DETECTION OF VASCULAR DISEASES TO DRIVE GROWTH
9.6 PEDIATRIC
9.6.1 LEVERAGING PEDIATRIC PORTABLE ULTRASOUND TO COMBAT NEONATAL MORTALITY
9.7 UROLOGY
9.7.1 PORTABLE ULTRASOUND WIDELY USED IN DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS
9.7.2 PAIN MANAGEMENT
9.7.2.1 Increasing adoption of portable ultrasound in outpatient settings to drive growth

10 PORTABLE ULTRASOUND MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 Presence of advanced healthcare infrastructure to drive market
10.2.3 CANADA
10.2.3.1 New product launch & conference events to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK
10.3.2 GERMANY
10.3.2.1 Rapid expansion in applications of portable ultrasound technologies to drive market
10.3.3 UK
10.3.3.1 Increase in awareness about different diagnostic imaging procedures to drive market
10.3.4 FRANCE
10.3.4.1 Increasing demand for portable ultrasound devices for routine health check-ups, prenatal care, and diagnostic procedures to drive market
10.3.5 ITALY
10.3.5.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market
10.3.6 SPAIN
10.3.6.1 Growing adoption of point-of-care portable ultrasound to drive market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK
10.4.2 CHINA
10.4.2.1 Emphasis on modernization and expansion of rural healthcare infrastructure to drive market
10.4.3 JAPAN
10.4.3.1 Established healthcare infrastructure and research facilities to drive market
10.4.4 INDIA
10.4.4.1 Rising adoption of advanced diagnostic imaging technologies to drive market
10.4.5 AUSTRALIA
10.4.5.1 Increasing investments in healthcare infrastructure to drive market
10.4.6 SOUTH KOREA
10.4.6.1 Rising investments in disease diagnostic system development to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Growing adoption of healthcare insurance to drive market
10.5.3 MEXICO
10.5.3.1 Investment in portable ultrasound devices to drive market
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.2.1 Government initiatives aimed at digital health and telemedicine to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PORTABLE ULTRASOUND MARKET
11.3 REVENUE ANALYSIS, 2021-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: PORTABLE ULTRASOUND MARKET, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Product type footprint
11.5.5.3 Platform footprint
11.5.5.4 Application footprint
11.5.5.5 End user footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
11.9.2 DEALS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 GE HEALTHCARE
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches
12.1.1.3.2 Deals
12.1.1.3.3 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 PHILIPS HEALTHCARE
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 CANON MEDICAL SYSTEMS CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 SIEMENS HEALTHINEERS AG
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 FUJIFILM CORPORATION
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 HOLOGIC, INC.
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 SAMSUNG ELECTRONICS CO., LTD.
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Product launches
12.1.7.3.2 Deals
12.1.7.3.3 Other developments
12.1.8 MINDRAY MEDICAL INTERNATIONAL LIMITED
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.8.3.2 Deals
12.1.9 ESAOTE SPA
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Product launches
12.1.9.3.2 Other developments
12.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.11 NEUSOFT CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Product launches
12.1.12 KONICA MINOLTA, INC.
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.13 CLARIUS
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Product launches and approvals
12.1.13.3.2 Deals
12.1.14 MEDGYN PRODUCTS, INC.
12.1.14.1 Business overview
12.1.14.1.1 Products offered
12.1.15 PROMED TECHNOLOGY CO., LTD.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER COMPANIES
12.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
12.2.2 PERLONG MEDICAL EQUIPMENT CO., LTD.
12.2.3 YOUKEY MEDICAL
12.2.4 SIUI
12.2.5 TELEMED, MEDICAL IMAGING EQUIPMENT DESIGN & MANUFACTURING
12.2.6 BUTTERFLY NETWORK, INC.
12.2.7 ALPINION MEDICAL SYSTEMS
12.2.8 EDAN INSTRUMENTS, INC.
12.2.9 SHENZHEN LANDWIND INDUSTRY CO., LTD
12.2.10 ECHONOUS INC.
12.2.11 MOBISANTE
12.2.12 SHENZHEN WISONIC MEDICAL TECHNOLOGY CO., LTD
12.2.13 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD
12.2.14 SONOSCAPE MEDICAL CORP
12.2.15 CURA HEALTHCARE

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

この商品のレポートナンバー

0000042089

最近見たレポート

トブラマイシン硫酸塩注射液の世界市場洞察(2024年)- 2029年までの分析と予測(市場参加企業別、地域別、技術別、用途別、製品タイプ別)

Tobramycin Sulfate Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

2024/04/22

3,500 USD

心的外傷後ストレス障害(PTSD)治療の世界市場洞察(2024年)- 2029年までの分析と予測(市場参加企業別、地域別、技術別、製品タイプ別)

Post-Traumatic Stress Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

2024/04/03

3,500 USD

個別化細胞療法の世界市場レポート(2024年)

Personalized Cell Therapy Global Market Report 2024

2024/12/09

5,000 USD

世界のCD123標的療法市場動向、臨床試験、技術プラットフォーム、2025年の将来展望

Global CD123 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms and Future Outlook 2025

2025/07/01

3,000 USD

TOP